Press release: DMC Biotech Total Series A Fundraising Closes With $11.3 Million

DMC logoBoulder, CO, USA, December 16, 2019 – DMC Biotechnologies has completed additional closings as part of the Company’s Series A funding round which was led by Sofinnova Partners.  Boulder Ventures VII L.P. (BV) and SCG have now joined the Series A round bringing the total close to $11.3 million. Current investors Capricorn Partners and Breakthrough Energy Ventures also participated in the round.

Read more ...

Press Release: Patent Allowed for DMC’s Dynamic Metabolic Control Technology

DMC logoBoulder, CO, USA, December 9, 2019 – An essential patent has been allowed for DMC Biotechnologies’ Dynamic Metabolic Control technology.  

Patent number PCT/US2015/035306 with the title ‘Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves’ has been issued by the United Kingdom Intellectual Property Office (UKIPO) to Duke University. DMC has the exclusive license to the technology from Duke. 

“The last ten years have shown that bringing biobased products to market takes time. Our Dynamic Metabolic Control technology can accelerate commercialization by making fermentation scale-up more predictable, robust, and efficient. Receiving this patent allowance is another milestone for DMC and is meaningful to our team, our partners, and our investors,” said Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC.

Brand Perspectives
On Biomaterials


Download Now